Germany Likely to Allow AstraZeneca Vaccination for Those Aged 65 and Over
[Asia Economy Reporter Baek Kyunghwan] There are growing expectations that Germany may allow the AstraZeneca-Oxford COVID-19 vaccine to be administered to those aged 65 and older.
According to foreign media on the 28th, Thomas Mertens, chairman of the Standing Committee on Vaccination at the Robert Koch Institute (RKI), Germany's equivalent of the Centers for Disease Control and Prevention, appeared on ZDF broadcast on the 26th and made remarks suggesting the possibility of approving the AstraZeneca vaccine for the elderly.
Furthermore, Chairman Mertens mentioned that they are awaiting detailed information regarding a study by researchers at the University of Edinburgh in Scotland, which showed that the risk of hospitalization decreased by around 90% four weeks after receiving the AstraZeneca vaccine.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "$2,000 War Surcharge Imposed"... 834 Cases of SME Damages Reported Due to Middle East Conflict
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Meanwhile, the German Standing Committee on Vaccination recommended on the 28th of last month that the AstraZeneca vaccine be administered only to those aged 18 to 64, citing a lack of clinical trial data for those aged 65 and older. Besides Germany, countries such as France, Belgium, and Sweden have also limited the AstraZeneca vaccine administration to those under 65.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
